toopanda.com
67%
461
Sanofi and GSK Began Human Trials of Protein-Based COVID-19 Vaccine
The partnership of French drugmaker Sanofi S.A. (Sanofi) and Britain’s GlaxoSmithKline Plc (GSK) entered the global race for finding a COVID-19 vaccine as they declared to have started a human trial of their vaccine on Thursday, September 3, 2020.